Open Access<p>Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema</p>
Author(s) -
Rohit Varma,
Neil M. Bressler,
Quan V. Doan,
Iván J. Suñer,
Mark D. Danese,
Chantal Dolan,
Abraham P. Lee,
Jason S. Ehrlich,
Yamina Rajput
Publication year - 2020
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s236636
Subject(s) - medicine , ranibizumab , diabetic retinopathy , diabetic macular edema , ophthalmology , diabetes mellitus , population , clinical trial , bevacizumab , chemotherapy , environmental health , endocrinology
Estimate effects of ranibizumab on diabetic retinopathy (DR) severity in US Hispanic and non-Hispanic white persons with center-involved diabetic macular edema (DME) causing vision impairment for whom ranibizumab treatment would be considered.